Mesalamine 1.2 g/1 (Mesalamine TABLET, DELAYED RELEASE) 1.2 g/1

Mesalamine 1.2 g tablets are a delayed-release medication used to manage inflammatory bowel conditions. This oral treatment helps reduce inflammation in the colon and rectum.

Strength

1.2 g/1

Pack Size

120 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2245-22)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mesalamine is commonly used to treat ulcerative colitis, a type of inflammatory bowel disease. It works by reducing inflammation in the colon and rectum, helping to alleviate symptoms like diarrhea, abdominal pain, and rectal bleeding. Mesalamine tablets are designed for delayed release, ensuring the medication is delivered to the targeted areas of the digestive tract.

Side Effects

Mesalamine may cause common side effects such as headache, nausea, and abdominal pain. Some users might experience diarrhea or vomiting. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Mesalamine should be taken as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with known allergies to mesalamine or its components should avoid using this medication. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

Mesalamine may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs that affect the digestive system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using mesalamine.

Frequently Asked Questions

Mesalamine is primarily used to treat inflammatory bowel conditions, such as ulcerative colitis, by reducing inflammation in the colon and rectum.

Mesalamine works by targeting and reducing inflammation in the digestive tract, specifically in the colon and rectum.

Common side effects of mesalamine include headache, nausea, abdominal pain, diarrhea, and vomiting.

Mesalamine may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

The safety of mesalamine for long-term use should be discussed with a healthcare provider, who can assess individual health conditions and needs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.